glaxo aims profit
glaxosmithkline profits drugmaker recovery
cheap copies drugs paxil wellbutrin weak dollar profits sales confident drug pipeline deliver profits failure obesity drug garnier
afternoon price pence garnier absorbed sales generics managing grow continuing success products pipeline progress discontinued experimental treatment obesity disappointing clinical glaxo relying treatments conditions cancer diabetes depression allergies lift pace sales disappointing
